APA

K N. L., K N. L. & Kumar. (2022). In Silico studies of US -FDA approved drugs or drugs under clinical trial which violate lipinski's rule of 5. Bathinda: Central university of punjab.

Chicago

K Niyatha Lohithakshan, K Niyatha Lohithakshan and Kumar. 2022. In Silico studies of US -FDA approved drugs or drugs under clinical trial which violate lipinski's rule of 5. Bathinda: Central university of punjab.

Harvard

K N. L., K N. L. and Kumar. (2022). In Silico studies of US -FDA approved drugs or drugs under clinical trial which violate lipinski's rule of 5. Bathinda: Central university of punjab.

MLA

K Niyatha Lohithakshan, K Niyatha Lohithakshan and Kumar. In Silico studies of US -FDA approved drugs or drugs under clinical trial which violate lipinski's rule of 5. Bathinda: Central university of punjab. 2022.